deslorelin Report issue

Animal product Experimental
AACT ChEMBL MeSH PubChem

Active Ingredient History

NOW
  • Now
Deslorelin, sold under the brand names Ovuplant, SucroMate, and Suprelorin among others, is an injectable gonadotropin releasing hormone superagonist which is used in veterinary medicine for various indications.   Wikipedia

Chemistry

  • SMILES: CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5c[nH]c6ccccc56)NC(=O)[C@H](Cc7c[nH]cn7)NC(=O)[C@@H]8CCC(=O)N8
  • InChIKey: GJKXGJCSJWBJEZ-XRSSZCMZSA-N
  • Mol. Mass: 1282.47
  • ALogP: Missing data
  • ChEMBL Molecule:
    deslorelin  
More Chemistry

Pharmacology

Alternative names

6-trp-10-n-et-glynh2-lhrh | deslorelin | deslorelin acetate | d-trp(6)-n-et-d-glynh2(10)-lhrh | d-trp lhrh-pea | gnrh, trp(6)-n-et-glynh2(10)- | lhrh, trp(6)-n-et-glynh2(10)- | lhrh, tryptophyl(6)-n-ethylglycinamide(10)- | ovuplant | somagard | somagard [as acetate]

Organizations (3)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (7)


 

Adrenal Gland Neoplasms (Phase 1)

BRCA1 Protein (Phase 2)

Breast Neoplasms (Phase 2)

Dwarfism (Phase 2)

Growth Disorders (Phase 2)

Mutation (Phase 2)

Puberty, Precocious (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue